Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Clinical effectiveness and cost-effectiveness of Helicobacter pylori testing and treatment in patients receiving long-term ulcer prophylaxis.

Skog JH, Morreale AP, Plowman BK, Rapier R, Dole S.

Am J Health Syst Pharm. 2004 Mar 15;61(6):608-12. No abstract available.

PMID:
15061433
2.

H pylori in patients with peptic ulcer disease.

Strickland C.

J Fam Pract. 1998 Feb;46(2):117. No abstract available.

PMID:
9487314
3.

Treatment of Helicobacter pylori infection.

Vakil N.

Am J Ther. 1998 May;5(3):197-201. Review.

PMID:
10099059
4.
5.

Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis.

Ford AC, Delaney BC, Forman D, Moayyedi P.

Am J Gastroenterol. 2004 Sep;99(9):1833-55. Review.

PMID:
15330927
6.

[Helicobacter pylori eradication in ulcer patients. Quality of life improves, costs decline].

[No authors listed]

MMW Fortschr Med. 2003 Aug 21;145(33-34):55. German. No abstract available.

PMID:
14526577
7.

Treatment of peptic ulcer disease: is Helicobacter pylori a consideration?

Pajares JM, Carballo F, Blanco M.

Hepatogastroenterology. 1992 Feb;39 Suppl 1:40-4. Review. No abstract available.

PMID:
1349551
8.

A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancers.

Davies R, Crabbe D, Roderick P, Goddard JR, Raftery J, Patel P.

Health Care Manag Sci. 2002 Nov;5(4):249-58.

PMID:
12437272
9.

The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model.

Roderick P, Davies R, Raftery J, Crabbe D, Pearce R, Bhandari P, Patel P.

Health Technol Assess. 2003;7(6):1-86. Review. No abstract available.

10.

[Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].

Butorov IV, Osoianu IuP, Butorov SI, Maksimov VV.

Klin Med (Mosk). 2005;83(12):50-3. Russian.

PMID:
16502725
11.

H. pylori: scientific basis to patient cure.

Peura DA.

Rev Gastroenterol Mex. 2006 Aug;71 Suppl 1:31-3. Review. No abstract available.

PMID:
17037765
12.

Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients-a cost-effectiveness analysis.

You JH, Lau W, Lee IY, Yung M, Ching JY, Chan FK, Lee KK.

Int J Clin Pharmacol Ther. 2006 Apr;44(4):149-53.

PMID:
16625983
13.

[Cost-benefit analysis of conservative therapy of gastritis and peptic ulcer].

Schütz E, Stolte M.

Leber Magen Darm. 1994 Jul;24(4):147-9. German. No abstract available.

PMID:
7934607
14.

Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.

Ando T, Minami M, Mizuno T, Watanabe O, Ishiguro K, Ina K, Kusugami K, Nobata K, Nishiwaki T, Tsuzuki T, Shimada M, El-Omar E, Goto H.

Helicobacter. 2005 Oct;10(5):379-84.

PMID:
16181347
15.

[Farmacoeconomical estimation of efficiency of different schemes of eradication therapy of Helicobacter pylori infection in children].

Kashnikova SN, Shcherbakov PL, Kashnikov VV, Tatarinov PA, Shcherbakova MIu.

Eksp Klin Gastroenterol. 2008;(7):111-8. Russian.

PMID:
19334454
16.

Threshold analysis of Helicobacter pylori therapy.

Sonnenberg A.

Pharmacoeconomics. 1998 Oct;14(4):423-32.

PMID:
10344909
17.

Peptic ulcer disease and current approaches to Helicobacter pylori.

Hassall E.

J Pediatr. 2001 Apr;138(4):462-8. No abstract available.

PMID:
11295706
18.

Helicobacter pylori and non-malignant diseases.

Rokkas T, Simsek I, Ladas S.

Helicobacter. 2007 Oct;12 Suppl 1:20-2. Review.

PMID:
17727456
19.

Helicobacter pylori eradication as prevention against chronic peptic ulcer disease in children.

Maciorkowska E, Kaczmarski M, Skowrońska J, Cieśla JM, Chrzanowska U, Olejnik BT, Sacharewicz A, Ryszczuk E.

Rocz Akad Med Bialymst. 2005;50 Suppl 1:137-40.

PMID:
16119648
20.

CagA status and Helicobacter pylori eradication among dyspeptic patients.

Magalhães AF, Carvalhaes A, Natan-Eisig J, Paraíso-Ferraz JG, Trevisan M, Zaterkaad S.

Gastroenterol Hepatol. 2005 Oct;28(8):441-4.

PMID:
16185577

Supplemental Content

Support Center